On this episode of Stock Movers:

- Expedia (EXPE) gains and Instacart rises. Jefferies upgraded both to buy, saying a pullback in internet stocks on concerns about artificial intelligence disruptions has created buying opportunities.

- Sysco (SYY) falls after the US food distributor agreed to buy privately held Jetro Restaurant Depot LLC for $29.1 billion including debt.

- Viridian Therapeutics (VRDN) tumbles 40% after announcing topline results from a clinical trial in active thyroid eye disease.

On this episode of Stock Movers:
- Expedia (EXPE) gains and Instacart rises. Jefferies upgraded both to buy, saying a pullback in internet stocks on concerns about artificial intelligence disruptions has created buying opportunities.
- Sysco (SYY) falls after the US food distributor agreed to buy privately held Jetro Restaurant Depot LLC for $29.1 billion including debt.
- Viridian Therapeutics (VRDN) tumbles 40% after announcing topline results from a clinical trial in active thyroid eye disease.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. 

Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for five-minute conversations on today's biggest winners and losers in the stock market.&nbsp;
Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for news on today's biggest winners and losers in the stock market.

Stock Movers

Expedia Rises, Sysco Falls, Viridian Therapeutics Tumbles as Eye Drug’s Efficacy Data Fall Short

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/9c99f987-caf8-44bd-9c67-b41d00eabde0/transcript

On this episode of Stock Movers:
- Estee Lauder (EL) shares gain. The US beauty company and Spanish firm Puig confirmed talks about a potential business combination have ended. Analysts cite several reasons for the positive reaction to the termination of talks, including “aversion to large deals,” integration risk/potential dilution to shareholders, as well as distraction to core business and its Beauty Reimagined strategic plan. Some analysts see better M&A opportunities in fragrance, or in masstige/mass segments. 
- Imax (IMAX) shares jump. The Wall Street Journal reported the large-screen theater company is exploring a sale and has approached entertainment companies as potential buyers. The sale process is in early stages and may not result in a deal, the report states, citing people familiar with the situation
- Denali Therapeutics (DNLI) shares slide. The drug developer said a mid-stage study of an experimental therapy for Parkinson’s disease, with partner Biogen, did not meet its primary or secondary endpoints.

On this episode of Stock Movers: - Estee Lauder (EL) shares gain. The US beauty company and Spanish firm Puig confirmed talks about a potential business combination have ended. Analysts cite several reasons for the positive reaction to the termination of talks, including &ldquo;aversion to large deals,&rdquo; integration risk/potential dilution to shareholders, as well as distraction to core business and its Beauty Reimagined strategic plan. Some analysts see better M&amp;A opportunities in fragrance, or in masstige/mass segments. - Imax (IMAX) shares jump. The Wall Street Journal reported the large-screen theater company is exploring a sale and has approached entertainment companies as potential buyers. The sale process is in early stages and may not result in a deal, the report states, citing people familiar with the situation - Denali Therapeutics (DNLI) shares slide. The drug developer said a mid-stage study of an experimental therapy for Parkinson&rsquo;s disease, with partner Biogen, did not meet its primary or secondary endpoints.

Estee Lauder Gains, Imax Jumps, Denali Therapeutics Slides After Parkinson’s Drug Trial Failure

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/6620e40c-499e-4ed5-94b3-b45200f1a3ce/transcript

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Estee Lauder (EL) share are climbing following collapse of a proposed combination with Puig Brands that would have created one of the world’s largest fragrance and skincare companies. 
- IMAX Corp. (IMAX) shares jumped after the Wall Street Journal reported the large-screen theater company is exploring a sale and has approached entertainment companies as potential buyers.
- Ross Stores (ROST) shares are up after the off-price retailer boosted its comparable sales forecast for the full year. The firm also posted better-than-expected sales for the first quarter.

Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - Estee Lauder (EL) share are climbing following collapse of a proposed combination with Puig Brands that would have created one of the world&rsquo;s largest fragrance and skincare companies. - IMAX Corp. (IMAX) shares jumped after the Wall Street Journal reported the large-screen theater company is exploring a sale and has approached entertainment companies as potential buyers. - Ross Stores (ROST) shares are up after the off-price retailer boosted its comparable sales forecast for the full year. The firm also posted better-than-expected sales for the first quarter.

Estee Lauder and IMAX Higher; Ross Stores Boost

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/e69d9445-9e5a-4883-a218-b45200d967ce/transcript

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers:

- BJ's Wholesale (BJ) shares are moving after it reported adjusted earnings per share for the first quarter that beat the average analyst estimate.

- Tiger Brokers (TIGR) is sliding as China’s securities regulator plans to penalize Futu Holdings Ltd., UP Fintech Holding Ltd.’s Tiger Brokers and Longbridge Securities Ltd. for operating on the mainland without a license, marking a sharp escalation in a yearslong campaign against illicit cross-border brokerages.

- Estee Lauder (EL) share are climbing following collapse of a proposed combination with Puig Brands that would have created one of the world’s largest fragrance and skincare companies. 

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- BJ's Wholesale (BJ) shares are moving after it reported adjusted earnings per share for the first quarter that beat the average analyst estimate.
- Tiger Brokers (TIGR) is sliding as China&rsquo;s securities regulator plans to penalize Futu Holdings Ltd., UP Fintech Holding Ltd.&rsquo;s Tiger Brokers and Longbridge Securities Ltd. for operating on the mainland without a license, marking a sharp escalation in a yearslong campaign against illicit cross-border brokerages.
- Estee Lauder (EL) share are climbing following collapse of a proposed combination with Puig Brands that would have created one of the world&rsquo;s largest fragrance and skincare companies.&nbsp;

BJ's Wholesale Reports; Tiger Brokers Drops; Estee Lauder Climbs

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/b2ca0199-aa0b-406e-8825-b45200b695d0/transcript

Expedia Rises, Sysco Falls, Viridian Therapeutics Tumbles as Eye Drug’s Efficacy Data Fall Short

In 1 playlist(s)

Stock Movers

Social links

Follow podcast

Recent clips